Medicenna Therapeutics Corp. announced that Ms. Rosemina Merchant and Dr. Chandrakant Panchal decided not to stand for re-election at the Meeting at its annual and special meeting of shareholders held on September 28, 2023. Ms. Merchant remains the Chief Development Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 CAD | +0.85% | +3.96% | +461.90% |
May. 22 | Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum | MT |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+461.90% | 129M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- Medicenna Therapeutics Corp. Announces Board Resignations